Literature DB >> 22212087

Prostate cancer and inflammation: the evidence.

Karen S Sfanos1, Angelo M De Marzo.   

Abstract

Chronic inflammation is now known to contribute to several forms of human cancer, with an estimated 20% of adult cancers attributable to chronic inflammatory conditions caused by infectious agents, chronic non-infectious inflammatory diseases and/or other environmental factors. Indeed, chronic inflammation is now regarded as an 'enabling characteristic' of human cancer. The aim of this review is to summarize the current literature on the evidence for a role for chronic inflammation in prostate cancer aetiology, with a specific focus on recent advances regarding the following: (i) potential stimuli for prostatic inflammation; (ii) prostate cancer immunobiology; (iii) inflammatory pathways and cytokines in prostate cancer risk and development; (iv) proliferative inflammatory atrophy (PIA) as a risk factor lesion to prostate cancer development; and (v) the role of nutritional or other anti-inflammatory compounds in reducing prostate cancer risk.
© 2011 Blackwell Publishing Limited.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22212087      PMCID： PMC4029103          DOI： 10.1111/j.1365-2559.2011.04033.x

Source DB:  PubMed          Journal:  Histopathology        ISSN： 0309-0167            Impact factor:   5.087


  161 in total

1.  The therapeutic implications of intratumoral regulatory T cells.

Authors:  Glenn Dranoff
Journal:  Clin Cancer Res       Date:  2005-12-01       Impact factor: 12.531

2.  Acne in adolescence and cause-specific mortality: lower coronary heart disease but higher prostate cancer mortality: the Glasgow Alumni Cohort Study.

Authors:  B Galobardes; G Davey Smith; M Jeffreys; S Kinra; P McCarron
Journal:  Am J Epidemiol       Date:  2005-06-15       Impact factor: 4.897

3.  Cytotoxic necrotizing factor type 1-positive Escherichia coli causes increased inflammation and tissue damage to the prostate in a rat prostatitis model.

Authors:  K E Rippere-Lampe; M Lang; H Ceri; M Olson; H A Lockman; A D O'Brien
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

4.  The dietary charred meat carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine acts as both a tumor initiator and promoter in the rat ventral prostate.

Authors:  Yasutomo Nakai; William G Nelson; Angelo M De Marzo
Journal:  Cancer Res       Date:  2007-01-30       Impact factor: 12.701

5.  Alpha 1 antichymotrypsin genotype is associated with increased risk of prostate carcinoma and PSA levels.

Authors:  Federico Licastro; Alessandro Bertaccini; Elisa Porcellini; Martina Chiappelli; Remigio Pernetti; Francesco Sanguedolce; Debora Marchiori; Giuseppe Martorana
Journal:  Anticancer Res       Date:  2008 Jan-Feb       Impact factor: 2.480

6.  Sexually transmissible infections and prostate cancer risk.

Authors:  Wen-Yi Huang; Richard Hayes; Ruth Pfeiffer; Raphael P Viscidi; Francis K Lee; Yun F Wang; Douglas Reding; Denise Whitby; John R Papp; Charles S Rabkin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-09       Impact factor: 4.254

7.  Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate.

Authors:  Georg E Steiner; Martin E Newman; Doris Paikl; Ursula Stix; Nima Memaran-Dagda; Chung Lee; Michael J Marberger
Journal:  Prostate       Date:  2003-08-01       Impact factor: 4.104

8.  A prospective study on dietary fat and incidence of prostate cancer (Malmö, Sweden).

Authors:  Peter Wallström; Anders Bjartell; Bo Gullberg; Håkan Olsson; Elisabet Wirfält
Journal:  Cancer Causes Control       Date:  2007-08-29       Impact factor: 2.506

9.  (n-6) PUFA increase and dairy foods decrease prostate cancer risk in heavy smokers.

Authors:  Marian L Neuhouser; Matt J Barnett; Alan R Kristal; Christine B Ambrosone; Irena King; Mark Thornquist; Gary Goodman
Journal:  J Nutr       Date:  2007-07       Impact factor: 4.798

10.  Aggressiveness of inflammation in histological prostatitis--correlation with total and free prostate specific antigen levels in men with biochemical criteria for prostate biopsy.

Authors:  G Stimac; A Reljic; B Spajic; J Dimanovski; B Ruzic; M Ulamec; Z Sonicki; O Kraus
Journal:  Scott Med J       Date:  2009-08       Impact factor: 0.729
View more
  231 in total

1.  Chronic Inflammation in Prostate Biopsy Cores is an Independent Factor that Lowers the Risk of Prostate Cancer Detection and is Inversely Associated with the Number of Positive Cores in Patients Elected to a First Biopsy.

Authors:  Antonio B Porcaro; Giovanni Novella; Daniele Mattevi; Leonardo Bizzotto; Giovanni Cacciamani; Nicolò De Luyk; Irene Tamanini; Maria A Cerruto; Matteo Brunelli; Walter Artibani
Journal:  Curr Urol       Date:  2016-05-20

Review 2.  Epigenetic susceptibility factors for prostate cancer with aging.

Authors:  N A Damaschke; B Yang; S Bhusari; J P Svaren; D F Jarrard
Journal:  Prostate       Date:  2013-09-02       Impact factor: 4.104

3.  A peripheral circulating TH1 cytokine profile is inversely associated with prostate cancer risk in CLUE II.

Authors:  Nrupen A Bhavsar; Jay H Bream; Alan K Meeker; Charles G Drake; Sarah B Peskoe; Djeneba Dabitao; Angelo M De Marzo; William B Isaacs; Elizabeth A Platz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-08-22       Impact factor: 4.254

Review 4.  [Familial prostate cancer and genetic predisposition].

Authors:  V H Meissner; M Jahnen; K Herkommer
Journal:  Urologe A       Date:  2021-03-15       Impact factor: 0.639

5.  Diet-related inflammation and risk of prostate cancer in the California Men's Health Study.

Authors:  Daria M McMahon; James B Burch; James R Hébert; James W Hardin; Jiajia Zhang; Michael D Wirth; Shawn D Youngstedt; Nitin Shivappa; Steven J Jacobsen; Bette Caan; Stephen K Van Den Eeden
Journal:  Ann Epidemiol       Date:  2018-11-02       Impact factor: 3.797

6.  Vasectomy: potential links to an increased risk of aggressive prostate cancer?

Authors:  Alexis R Gaines; Adriana C Vidal; Stephen J Freedland
Journal:  Expert Rev Anticancer Ther       Date:  2015-09-07       Impact factor: 4.512

7.  A mouse model of chronic prostatic inflammation using a human prostate cancer-derived isolate of Propionibacterium acnes.

Authors:  Debika Biswal Shinohara; Ajay M Vaghasia; Shu-Han Yu; Tim N Mak; Holger Brüggemann; William G Nelson; Angelo M De Marzo; Srinivasan Yegnasubramanian; Karen S Sfanos
Journal:  Prostate       Date:  2013-02-06       Impact factor: 4.104

Review 8.  Future directions in the prevention of prostate cancer.

Authors:  Ian M Thompson; April B Cabang; Michael J Wargovich
Journal:  Nat Rev Clin Oncol       Date:  2013-11-26       Impact factor: 66.675

9.  Lineage Plasticity in Cancer Progression and Treatment.

Authors:  Clémentine Le Magnen; Michael M Shen; Cory Abate-Shen
Journal:  Annu Rev Cancer Biol       Date:  2017-12-01

10.  Tumor-infiltrating mesenchymal stem cells: Drivers of the immunosuppressive tumor microenvironment in prostate cancer?

Authors:  Timothy E Krueger; Daniel L J Thorek; Alan K Meeker; John T Isaacs; W Nathaniel Brennen
Journal:  Prostate       Date:  2018-11-28       Impact factor: 4.104
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.